Comment Repository

These comments were made on behalf of those associations listed as signatories and not on behalf of the Food and Beverage Issue Alliance (FBIA)

2024

• September 4, 2024: Re. 2025 Dietary Guidelines Advisory Committee - Docket No. HHS-OASH-2022-0021-0001

• August 13, 2024: RE. Listening Session: Optimizing FDA’s Use of and Process for Advisory Committees - Docket No. FDA-2024-N-1809

• August 2, 2024: RE. Draft Guidance for Industry on Hazard Analysis and Risk-Based Preventive Controls for Human Food; Appendix 1 (“the revised Appendix 1”) - Docket No. FDA-2016-D-2343

• June 12, 2024: RE: Front-of-Pack Nutrition Labeling Research

• May 24, 2024: RE: Hazard Analysis and Risk-Based Preventive Controls for Human Food: Draft Guidance for Industry1; Chapter 11 (Docket (FDA-2023-N-4849)

• February 26, 2024; RE: 2025 Dietary Guidelines Advisory Committee (Docket No. HHS-OASH-2022-0021-0001)

• January 22, 2024; RE: The FDA Virtual Public Meeting and Listening Sessions on Strategies to Reduce Added Sugars Consumption in the United States; Request for Comments - Docket No. FDA-2023-N-3849

2023

• October 27, 2023; Re: Public Meeting: Modernizing Recalls of FDA-Regulated Commodities; Docket No. FDA-2023-N-2393

• September 27, 2023; Re. Jim Jones Congratulatory Letter

• September 1, 2023; Re. Filing of Color Additive Petition from Environmental Defense Fund, et al.; Request to Revoke Color Additive Listing for Use of Titanium Dioxide in Food (Docket No. FDA-2023-C-1487)

• July 17, 2023; Re: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Quantitative Research on Front of Package Labeling on Packaged Foods; Docket No. FDA-2023-N-0155

• May 8, 2023; Re.: 2025 Dietary Guidelines Advisory Committee (Docket No. HHS-OASH-2022-0021-0001

• April 10, 2023; Re. Use of Salt Substitutes to Reduce the Sodium Content in Standardized Foods; Docket No. FDA-2022-N-2226

• March 27, 2023; Re. Action Levels for Lead in Food Intended for Babies and Young Children: Draft Guidance for Industry (Docket No. FDA-2022-D-0278)

• March 27, 2023; Re: Agency Information Collection Activities; Proposed Collection; Comment Request; Quantitative Research on Front of Package Labeling on Packaged Foods, Docket No. FDA-2023-N-0155

• February 16, 2023; Re: Food Labeling: Nutrient Content Claims; Definition of Term “Healthy”, Docket No. FDA-2016-D-2335

• February 15, 2023; Re. PHE Declaration

• January 9, 2023; Re. Guides for the Use of Environmental Marketing Claims (Green Guides Review, Matter No. P954501) (Docket FTC-2022-0077)

2022

• November 16, 2022; Re: Follow-up to FBIA/FDA meeting on “Appendix 1: Potential Hazards for Foods and Processes” Docket No. FDA–2016–D–2343

• October 20, 2022; Re. REQUEST FOR EXTENSION OF COMMENT PERIOD: Food Labeling: Nutrient Content Claims: Definition of Term “Healthy" Docket No. FDA-2016-D-2335

• August 20, 2022; Re. FBIA Follow Up Letter to FDA on Supply Chain Disruptions

• May 16, 2022; Re: Request for Comments on Scientific Questions To Be Examined To Support the Development of the Dietary Guidelines for Americans, 2025-2030 (Docket No. HHS-OASH-2022-0005-0001)

• April 27, 2022; Re. FBIA Feedback on Supply Chain Disruptions

• March 29, 2022; Re. Commissioner Califf Congratulatory Letter from FBIA